Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

被引:18
|
作者
Walker, Christopher J. [1 ]
Kohlschmidt, Jessica [1 ,2 ]
Eisfeld, Ann-Kathrin [1 ]
Mrozek, Krzysztof [1 ]
Liyanarachchi, Sandya [1 ]
Song, Chi [3 ]
Nicolet, Deedra [1 ,2 ]
Blachly, James S. [1 ]
Bill, Marius [1 ]
Papaioannou, Dimitrios [1 ]
Oakes, Christopher C. [1 ]
Giacopelli, Brian [1 ]
Genutis, Luke K. [1 ]
Maharry, Sophia E. [1 ]
Orwick, Shelley [1 ]
Archer, Kellie J. [1 ,3 ]
Powell, Bayard L. [4 ]
Kolitz, Jonathan E. [5 ]
Uy, Geoffrey L. [6 ]
Wang, Eunice S. [7 ]
Carroll, Andrew J. [8 ]
Stone, Richard M. [9 ]
Byrd, John C. [1 ]
de la Chapelle, Albert [1 ]
Bloomfield, Clara D. [1 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Biomed Res Tower,Room 894,460 W 12th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Alliance Stat & Data Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA
[4] Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC USA
[5] Zucker Sch Med Hofstra Northwell, Monter Canc Ctr, Lake Success, NY USA
[6] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63110 USA
[7] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
GROUP-B; DOSE CYTARABINE; CEBPA MUTATIONS; AGE; 60; CANCER; ADULTS; IMPACT; AML; CHEMOTHERAPY; NUMBER;
D O I
10.1158/1078-0432.CCR-19-0725
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Uniparental disomy (UPD) is a way cancer cells duplicate a mutated gene, causing loss of heterozygosity (LOH). Patients with cytogenetically normal acute myeloid leukemia (CN-AML) do not have microscopically detectable chromosome abnormalities, but can harbor UPDs. We examined the prognostic significance of UPDs and frequency of LOH in patients with CN-AML. Experimental Design: We examined the frequency and prognostic significance of UPDs in a set of 425 adult patients with de novo CN-AML who were previously sequenced for 81 genes typically mutated in cancer. Associations of UPDs with outcome were analyzed in the 315 patients with CN-AML younger than 60 years. Results: We detected 127 UPDs in 109 patients. Most UPDs were large and typically encompassed all or most of the affected chromosome arm. The most common UPDs occurred on chromosome arms 13q (7.5% of patients), 6p (2.8%), and 11p (2.8%). Many UPDs significantly cooccurred with mutations in genes they encompassed, including 13q UPD with FLT3-internal tandem duplication (FLT3-ITD; P < 0.001), and 11p UPD with WT1 mutations (P = 0.02). Among patients younger than 60 years, UPD of 11p was associated with longer overall survival (OS) and 13q UPD with shorter disease-free survival (DFS) and OS. In multivariable models that accounted for known prognostic markers, including FLT3-ITD and WT1 mutations, UPD of 13q maintained association with shorter DFS, and UPD of 11p maintained association with longer OS. Conclusions: LOH mediated by UPD is a recurrent feature of CN-AML. Detection of UPDs of 13q and 11p might be useful for genetic risk stratification of patients with CN-AML.
引用
收藏
页码:6524 / 6531
页数:8
相关论文
共 50 条
  • [21] Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model
    Yang, Liu
    Zhang, Houyu
    Yang, Xue
    Lu, Ting
    Ma, Shihui
    Cheng, Hui
    Yen, Kuangyu
    Cheng, Tao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia
    Cao, Ling
    Zhang, Weilong
    Liu, Xiaoni
    Yang, Ping
    Wang, Jing
    Hu, Kai
    Zhang, Xiuru
    Liu, Weiyou
    He, Xue
    Jing, Hongmei
    Yuan, Xiaoliang
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Distinct Expression Patterns in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) Characterized by Uniparental Disomy
    Bullinger, Lars
    Kronke, Jan
    Botzenhardt, Ursula
    Heinrich, Sabrina
    Urlbauer, Katja
    Miller, Simone
    Schon, Christian
    Schlenk, Richard F.
    Holzmann, Karlheinz
    Dohner, Konstanze
    Dohner, Hartmut
    BLOOD, 2008, 112 (11) : 435 - 435
  • [24] Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients
    Guolo, Fabio
    Minetto, Paola
    Clavio, Marino
    Marcolin, Riccardo
    Miglino, Maurizio
    Passannante, Monica
    Caviglia, Fabrizio
    Ballerini, Filippo
    Tedone, Elisabetta
    Kunkl, Annalisa
    Mangerini, Rosa
    Contini, Paola
    Colombo, Nicoletta
    Cagnetta, Antonia
    Cea, Michele
    Carminati, Enrico
    Pugliese, Girolamo
    Gobbi, Marco
    Lemoli, Roberto Massimo
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1695 - 1701
  • [25] Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
    Papaioannou, Dimitrios
    Nicolet, Deedra
    Ozer, Hatice G.
    Mrozek, Krzysztof
    Volinia, Stefano
    Fadda, Paolo
    Carroll, Andrew J.
    Kohlschmidt, Jessica
    Kolitz, Jonathan E.
    Wang, Eunice S.
    Stone, Richard M.
    Byrd, John C.
    Garzon, Ramiro
    Bloomfield, Clara D.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (08) : 1451 - 1459
  • [26] Characterization and prognostic significance of cytogenetically unrelated clones in myelodysplastic syndromes and acute myeloid leukemia
    Schanz, J.
    Kessels, S.
    Haferlach, C.
    Bardi, G.
    Gourgouveli, E.
    Slovak, M. L.
    Johansson, B.
    Ohyashiki, K.
    Sole, F.
    Eclache, V
    Wimzal, F.
    Pfeilstoecker, M.
    Noesslinger, T.
    Fonatsch, C.
    Luebbert, M.
    Giagounidis, A.
    Stauder, R.
    Krieger, O.
    Prescher, G.
    Hildebrandt, B.
    Greenberg, P.
    LeBeau, M. M.
    Bennett, J. M.
    Germing, U.
    Haase, D.
    ONKOLOGIE, 2011, 34 : 8 - 8
  • [27] Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia
    Pastore, Friederike
    Dufour, Annika
    Benthaus, Tobias
    Metzeler, Klaus H.
    Maharry, Kati S.
    Schneider, Stephanie
    Ksienzyk, Bianka
    Mellert, Gudrun
    Zellmeier, Evelyn
    Kakadia, Purvi M.
    Unterhalt, Michael
    Feuring-Buske, Michaela
    Buske, Christian
    Braess, Jan
    Sauerland, Maria Cristina
    Heinecke, Achim
    Krug, Utz
    Berdel, Wolfgang E.
    Buechner, Thomas
    Woermann, Bernhard
    Hiddemann, Wolfgang
    Bohlander, Stefan K.
    Marcucci, Guido
    Spiekermann, Karsten
    Bloomfield, Clara D.
    Hoster, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) : 1586 - U88
  • [28] Segmental uniparental disomy is the most commonly acquired genetic abnormality in relapsed acute myeloid leukemia
    Raghavan, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 324 - 324
  • [29] Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
    Schlenk, Richard F.
    Doehner, Konstanze
    Krauter, Juergen
    Froehling, Stefan
    Corbacioglu, Andrea
    Bullinger, Lars
    Habdank, Marianne
    Spaeth, Daniela
    Morgan, Michael
    Benner, Axel
    Schlegelberger, Brigitte
    Heil, Gerhard
    Ganser, Arnold
    Doehner, Hartmut
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18): : 1909 - 1918
  • [30] Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
    Ling, Victoria Y.
    Lee, Denise
    Mcquilten, Zoe
    Avery, Sharon
    Low, Michael
    Cody, Stephen H.
    Trung Nguyen
    Mclean, Catriona
    Gorniak, Malgorzata
    Wei, Andrew
    Ting, Stephen B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : E219 - E220